Septerna (SEPN) Change in Acquisitions & Divestments (2024 - 2026)
Septerna's quarterly Change in Acquisitions & Divestments came in at $82.2 million in Q1 2026, up 81.87% year-on-year from $45.2 million in Q1 2025, and up 94.89% quarter-over-quarter from $42.2 million in Q4 2025.
Septerna has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $82.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 81.87% year-over-year to $82.2 million; the trailing twelve-month figure through Mar 2026 stood at $246.6 million (up 218.27% YoY), and the FY2025 full-year result was $209.6 million, up 549.57% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $82.2 million, up from $42.2 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $82.2 million in Q1 2026, with the low at $7.9 million in Q2 2024.
- Average Change in Acquisitions & Divestments over 3 years is $40.5 million, with a median of $43.7 million recorded in 2025.
- Year-over-year, Change in Acquisitions & Divestments jumped 697.94% in 2025 and jumped 81.87% in 2026.
- Tracing SEPN's Change in Acquisitions & Divestments over 3 years: stood at $14.9 million in 2024, then soared by 182.56% to $42.2 million in 2025, then jumped by 94.89% to $82.2 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $82.2 million (Q1 2026), $42.2 million (Q4 2025), and $59.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.25 Mn |
| Mar 31, 2026 | 82.25 Mn |
| Dec 31, 2025 | 42.20 Mn |
| Dec 31, 2025 | 42.20 Mn |
| Sep 30, 2025 | 59.08 Mn |
| Sep 30, 2025 | 59.08 Mn |
| Jun 30, 2025 | 63.12 Mn |
| Jun 30, 2025 | 63.12 Mn |
| Mar 31, 2025 | 45.22 Mn |
| Mar 31, 2025 | 45.22 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Sep 30, 2024 | 9.43 Mn |
| Sep 30, 2024 | 9.43 Mn |
| Jun 30, 2024 | 7.91 Mn |
| Jun 30, 2024 | 7.91 Mn |